Valeo Pharma Inc.
Valeo Pharma Inc., a prominent Canadian pharmaceutical company, is headquartered in Laval, Quebec, with significant operations across North America. Founded in 2003, Valeo Pharma has established itself in the healthcare industry, focusing on the development and commercialisation of innovative prescription medications. The company’s core product offerings include a range of therapeutic solutions in areas such as oncology, neurology, and respiratory health, distinguished by their commitment to addressing unmet medical needs. Valeo Pharma has achieved notable milestones, including strategic partnerships and product launches that have solidified its market position. With a dedication to enhancing patient outcomes, Valeo Pharma continues to make strides in the pharmaceutical landscape, driven by a robust pipeline and a focus on quality and efficacy.
DitchCarbon Score
How does Valeo Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Valeo Pharma Inc.'s score of 23 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Valeo Pharma Inc.'s reported carbon emissions
Valeo Pharma Inc., headquartered in Canada, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the absence of reported emissions data may indicate that the company is in the early stages of developing its sustainability strategy or is working towards establishing a framework for measuring and reporting its environmental impact. As the pharmaceutical industry increasingly prioritises sustainability, Valeo Pharma may be expected to align with industry standards and set future climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Valeo Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
